Berkeley Lights to Participate in the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Berkeley Lights, a leader in Digital Cell Biology, will participate in the 39th Annual J.P. Morgan Virtual Healthcare Conference on January 12, 2021, at 11:00 a.m. PT / 2:00 p.m. ET. A live and archived webcast of the presentation can be accessed through the company’s website. The company focuses on accelerating the development of biotherapeutics and cell-based products through its platform that captures phenotypic and genotypic information from single cells.

EMERYVILLE, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating in the upcoming 39^th Annual J.P. Morgan Virtual Healthcare Conference.

Berkeley Lights’ management is scheduled to present on Tuesday, January 12 at 11:00 a.m. Pacific Time / 2:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.berkeleylights.com.

About Berkeley Lights
Berkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelect^TM chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights Platform to provide the most advanced environment for rapid functional characterization of single cells at scale, the goal of which is to establish an industry standard for our customers throughout their cell-based product value chain.

Berkeley Lights’ Beacon^® and Lightning^TM systems and Culture Station^TM instrument are FOR RESEARCH USE ONLY. Not for use in diagnostic procedures.

Press Contact
berkeleylights@bulleitgroup.com

Investor Contact
ir@berkeleylights.com

FAQ

When is Berkeley Lights participating in the J.P. Morgan Healthcare Conference 2021?

Berkeley Lights will participate in the J.P. Morgan Virtual Healthcare Conference on January 12, 2021, at 11:00 a.m. PT.

How can I access Berkeley Lights' conference presentation?

You can access the live and archived webcast of Berkeley Lights' presentation on their website in the 'Investors' section.

What is the focus of Berkeley Lights' technology?

Berkeley Lights focuses on Digital Cell Biology to enable and accelerate the development of biotherapeutics and cell-based products.

What time will Berkeley Lights' presentation start at the conference?

Berkeley Lights' presentation will start at 11:00 a.m. Pacific Time / 2:00 p.m. Eastern Time.

Is Berkeley Lights' technology available for diagnostic procedures?

No, Berkeley Lights' Beacon and Lightning systems are for research use only and not for use in diagnostic procedures.